Literature DB >> 25877626

Migraine and multiple sclerosis: Epidemiology and approach to treatment.

Amy A Gelfand1, Jeffrey M Gelfand2, Peter J Goadsby3.   

Abstract

Migraine is a highly prevalent neurological condition that commonly affects patients with multiple sclerosis (MS). In this review, we examine the case for a clinical and epidemiological association between migraine and MS and discuss how to diagnose and treat migraine effectively in MS patients. If there is an epidemiologic association between MS and migraine, a causal relationship remains to be demonstrated and the effect-size, at best, appears to be small. Accurate diagnosis of migraine in MS patients is important for improving care by (1) distinguishing symptoms related to MS versus migraine, (2) recognizing that migraineurs have altered sensory perception, which may influence the patient experience of certain MS-related symptoms, such as paresthesias and pain, (3) informing disease modifying therapy selection and (4) optimizing migraine treatment with appropriate preventive and acute therapy.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Disease-modifying therapy; Epidemiology; Headache; Migraine; Multiple sclerosis; Neuroimaging

Year:  2013        PMID: 25877626     DOI: 10.1016/j.msard.2012.10.003

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  9 in total

Review 1.  Headache and Its Management in Patients With Multiple Sclerosis.

Authors:  Farhat Husain; Gabriel Pardo; Meheroz Rabadi
Journal:  Curr Treat Options Neurol       Date:  2018-03-24       Impact factor: 3.598

Review 2.  Botulinum Toxin Treatment in Multiple Sclerosis-a Review.

Authors:  Yasaman Safarpour; Tahereh Mousavi; Bahman Jabbari
Journal:  Curr Treat Options Neurol       Date:  2017-08-17       Impact factor: 3.598

3.  Association Between Insomnia and Migraine Risk: A Case-Control and Bidirectional Mendelian Randomization Study.

Authors:  Shujuan Chu; Zhilin Wu; Zhouyang Wu; Jing Wu; Yue Qian
Journal:  Pharmgenomics Pers Med       Date:  2021-08-13

4.  Multiple sclerosis and primary vascular dysregulation (Flammer syndrome).

Authors:  Katarzyna Konieczka; Simone Koch; Tatjana Binggeli; Andreas Schoetzau; Juerg Kesselring
Journal:  EPMA J       Date:  2016-06-15       Impact factor: 6.543

5.  P037. Headache in multiple sclerosis: prevalence and clinical features in a case control-study.

Authors:  Rossana Terlizzi; Elena Merli; Elena Buccellato; Giulia Giannini; Valentina Favoni; Giulia Pierangeli; Fabrizio Salvi; Pietro Cortelli; Sabina Cevoli
Journal:  J Headache Pain       Date:  2015-12       Impact factor: 7.277

6.  Migraine and frequent tension-type headache are not associated with multiple sclerosis in a Norwegian case-control study.

Authors:  M W Gustavsen; E G Celius; B S Winsvold; S M Moen; G O Nygaard; P Berg-Hansen; B A Lie; J-A Zwart; H F Harbo
Journal:  Mult Scler J Exp Transl Clin       Date:  2016-12-12

7.  Status Migrainosus and Endometriosis: A Case Report and Review of the Literature.

Authors:  Lexi R Frankel; Richard Medina; Michael Ashley; Jose L Lopez; Livasky Concepion
Journal:  Cureus       Date:  2021-11-16

Review 8.  Neuropathic Pain in Neurologic Disorders: A Narrative Review.

Authors:  Dimos-Dimitrios Mitsikostas; Eleni Moka; Enrique Orrillo; Caterina Aurilio; Athina Vadalouca; Antonella Paladini; Giustino Varrassi
Journal:  Cureus       Date:  2022-02-20

9.  MRI evaluation of thalamic volume differentiates MS from common mimics.

Authors:  Andrew J Solomon; Richard Watts; Blake E Dewey; Daniel S Reich
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-07-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.